Nearly five years ago, DeepMind, one of Google's more prolific AI-centered research labs, debuted AlphaFold, an AI system that can accurately predict the structures of many proteins inside the human ...
Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming. One promising new ...
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
CAMBRIDGE, MA -- Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.
DeepMind, the AI unit of Google that invented the chess champ neural network AlphaZero a few years back, shocked the world again in November with a program that had solved a decades-old problem of how ...
Google DeepMind today detailed a new version of AlphaFold, an artificial intelligence model it has built to help researchers study biological molecules such as proteins. The Google LLC unit says the ...
Pharmaceutical researchers in the United Kingdom are using the artificial intelligence tool AlphaFold to develop new psychedelic drugs, according to research released last month. The research, which ...
Using protein structures generated by the AI software AlphaFold, researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds. Over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results